ACTRT3
geneOn this page
Also known as ARPM1
Summary
ACTRT3 (actin related protein T3, HGNC:24022) is a protein-coding gene on chromosome 3q26.2, encoding Actin-related protein T3 (Q9BYD9).
Predicted to be located in cytoplasm; cytoskeleton; and male germ cell nucleus. Predicted to be active in actin cytoskeleton.
Source: NCBI Gene 84517 — RefSeq curated summary.
At a glance
- GWAS associations: 11
- Clinical variants (ClinVar): 69 total — 1 pathogenic
- MANE Select transcript:
NM_032487
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:24022 |
| Approved symbol | ACTRT3 |
| Name | actin related protein T3 |
| Location | 3q26.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | ARPM1 |
| Ensembl gene | ENSG00000184378 |
| Ensembl biotype | protein_coding |
| OMIM | 608534 |
| Entrez | 84517 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000330368, ENST00000956146
RefSeq mRNA: 1 — MANE Select: NM_032487
NM_032487
CCDS: CCDS3206
Canonical transcript exons
ENST00000330368 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001292725 | 169769321 | 169769561 |
| ENSE00001326845 | 169766921 | 169768350 |
Expression profiles
Bgee: expression breadth ubiquitous, 162 present calls, max score 94.22.
FANTOM5 (CAGE): breadth broad, TPM avg 0.8165 / max 115.0267, expressed in 398 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 45532 | 0.2859 | 116 |
| 45531 | 0.2699 | 77 |
| 45533 | 0.2607 | 91 |
Top tissues by expression
247 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 94.22 | gold quality |
| left testis | UBERON:0004533 | 93.12 | gold quality |
| right testis | UBERON:0004534 | 92.86 | gold quality |
| testis | UBERON:0000473 | 91.10 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 89.54 | gold quality |
| adult organism | UBERON:0007023 | 86.53 | gold quality |
| endothelial cell | CL:0000115 | 74.56 | silver quality |
| stromal cell of endometrium | CL:0002255 | 73.52 | gold quality |
| calcaneal tendon | UBERON:0003701 | 70.04 | gold quality |
| mucosa of stomach | UBERON:0001199 | 68.76 | gold quality |
| right lobe of liver | UBERON:0001114 | 68.21 | gold quality |
| thoracic aorta | UBERON:0001515 | 66.58 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 66.44 | gold quality |
| islet of Langerhans | UBERON:0000006 | 66.33 | gold quality |
| ascending aorta | UBERON:0001496 | 66.23 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 66.06 | gold quality |
| left uterine tube | UBERON:0001303 | 65.93 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 65.92 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 65.53 | gold quality |
| lower esophagus | UBERON:0013473 | 65.49 | gold quality |
| left coronary artery | UBERON:0001626 | 63.97 | gold quality |
| right coronary artery | UBERON:0001625 | 63.95 | gold quality |
| liver | UBERON:0002107 | 63.71 | gold quality |
| omental fat pad | UBERON:0010414 | 63.59 | gold quality |
| peritoneum | UBERON:0002358 | 63.57 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 63.53 | gold quality |
| adipose tissue of abdominal region | UBERON:0007808 | 63.23 | gold quality |
| prefrontal cortex | UBERON:0000451 | 63.09 | gold quality |
| metanephros cortex | UBERON:0010533 | 63.09 | gold quality |
| right atrium auricular region | UBERON:0006631 | 63.03 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.71 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
18 targeting ACTRT3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-96-5P | 99.95 | 72.80 | 2140 |
| HSA-MIR-1236-3P | 99.94 | 68.04 | 1695 |
| HSA-MIR-12133 | 99.92 | 71.82 | 2006 |
| HSA-MIR-1271-5P | 99.91 | 71.99 | 1972 |
| HSA-MIR-4713-5P | 99.78 | 67.80 | 1794 |
| HSA-MIR-494-3P | 99.70 | 71.45 | 2795 |
| HSA-MIR-4743-3P | 99.62 | 68.12 | 2095 |
| HSA-MIR-182-3P | 99.57 | 67.57 | 825 |
| HSA-MIR-6853-3P | 99.36 | 70.79 | 1558 |
| HSA-MIR-4652-3P | 99.33 | 70.02 | 2742 |
| HSA-MIR-888-5P | 99.30 | 70.15 | 1855 |
| HSA-MIR-26B-3P | 98.71 | 67.49 | 1102 |
| HSA-MIR-6773-3P | 98.17 | 65.51 | 1213 |
| HSA-MIR-660-5P | 98.16 | 68.27 | 680 |
| HSA-MIR-4733-5P | 97.75 | 67.44 | 866 |
| HSA-MIR-7976 | 95.75 | 65.67 | 1186 |
| HSA-MIR-324-5P | 95.68 | 65.20 | 560 |
| HSA-MIR-874-3P | 95.02 | 65.66 | 806 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Actrt3 | ENSMUSG00000037737 |
| rattus_norvegicus | Actrt3 | ENSRNOG00000027908 |
Paralogs (26): ACTR6 (ENSG00000075089), ACTB (ENSG00000075624), ACTL6B (ENSG00000077080), ACTR5 (ENSG00000101442), ACTR3C (ENSG00000106526), ACTA2 (ENSG00000107796), ACTR8 (ENSG00000113812), ACTR1B (ENSG00000115073), ACTR3 (ENSG00000115091), ACTL8 (ENSG00000117148), ACTRT1 (ENSG00000123165), ACTR10 (ENSG00000131966), ACTR3B (ENSG00000133627), ACTL6A (ENSG00000136518), ACTR2 (ENSG00000138071), ACTR1A (ENSG00000138107), ACTA1 (ENSG00000143632), ACTL7B (ENSG00000148156), ACTC1 (ENSG00000159251), ACTG2 (ENSG00000163017), ACTBL2 (ENSG00000169067), ACTRT2 (ENSG00000169717), ACTL9 (ENSG00000181786), ACTG1 (ENSG00000184009), ACTL7A (ENSG00000187003), ACTL10 (ENSG00000288649)
Protein
Protein identifiers
Actin-related protein T3 — Q9BYD9 (reviewed: Q9BYD9)
Alternative names: Actin-related protein M1
All UniProt accessions (1): Q9BYD9
UniProt curated annotations — full annotation on UniProt →
Subunit / interactions. Interacts with PFN3.
Subcellular location. Cytoplasm. Cytoskeleton. Nucleus.
Tissue specificity. Ubiquitously expressed.
Similarity. Belongs to the actin family.
RefSeq proteins (1): NP_115876* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR004000 | Actin | Family |
| IPR020902 | Actin/actin-like_CS | Conserved_site |
| IPR043129 | ATPase_NBD | Homologous_superfamily |
Pfam: PF00022
UniProt features (4 total): sequence conflict 2, chain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BYD9-F1 | 94.47 | 0.90 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 46 (showing top):
chr3q26, GOCC_GERM_CELL_NUCLEUS, MARSON_BOUND_BY_FOXP3_STIMULATED, MARSON_BOUND_BY_FOXP3_UNSTIMULATED, GOMF_STRUCTURAL_CONSTITUENT_OF_CYTOSKELETON, GOMF_STRUCTURAL_MOLECULE_ACTIVITY, BRUINS_UVC_RESPONSE_EARLY_LATE, MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN, WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D, FOXN3_TARGET_GENES, SIPA1_TARGET_GENES, ZBTB12_TARGET_GENES, ZSCAN2_TARGET_GENES, MIR96_5P, MIR1271_5P
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (5): male germ cell nucleus (GO:0001673), cytoplasm (GO:0005737), actin cytoskeleton (GO:0015629), nucleus (GO:0005634), cytoskeleton (GO:0005856)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| germ cell nucleus | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
| cytoskeleton | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular membraneless organelle | 1 |
Protein interactions and networks
STRING
2100 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ACTRT3 | LRRIQ4 | A6NIV6 | 730 |
| ACTRT3 | MYNN | Q9NPC7 | 722 |
| ACTRT3 | LRRC34 | Q8IZ02 | 669 |
| ACTRT3 | PFN3 | P60673 | 584 |
| ACTRT3 | ZNF888 | P0CJ79 | 510 |
| ACTRT3 | LRRC31 | Q6UY01 | 479 |
| ACTRT3 | CFAP161 | Q6P656 | 438 |
| ACTRT3 | MYLK2 | Q9H1R3 | 414 |
| ACTRT3 | ACRBP | Q8NEB7 | 410 |
| ACTRT3 | ODF2 | Q5BJF6 | 406 |
| ACTRT3 | TNP1 | P09430 | 374 |
| ACTRT3 | INSYN2B | A6NMK8 | 366 |
| ACTRT3 | IZUMO4 | Q1ZYL8 | 366 |
| ACTRT3 | RNF113B | Q8IZP6 | 358 |
| ACTRT3 | B4DL54 | B4DL54 | 358 |
| ACTRT3 | SERTAD3 | Q9UJW9 | 358 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ACTRT3 | PDCL3 | psi-mi:“MI:0915”(physical association) | 0.500 |
| PDCL3 | POTEF | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (2): PDCL3 (Affinity Capture-MS), ACTRT3 (Affinity Capture-MS)
ESM2 similar proteins: A0JNU3, A2AKE7, A6H603, A6QQ74, D3ZBP4, F1MH07, O43542, Q149M9, Q2T9W4, Q2TA43, Q2V057, Q32KZ2, Q32L91, Q3ZBE0, Q49HH9, Q49KI5, Q4QR76, Q4R317, Q4R6Q3, Q4R821, Q5JWF8, Q5REQ1, Q5XIK1, Q641W9, Q643R3, Q68FW7, Q6AY16, Q6NVG1, Q76HM9, Q86U10, Q8CG27, Q8K4F6, Q8TC94, Q8TDG2, Q8TDY3, Q8TDZ2, Q8VCZ9, Q8VDP3, Q8VEI3, Q95JK8
Diamond homologs: A2XLF2, A3C6D7, A5DQP9, B5X2S3, D2I1E3, O74258, P02580, P0C539, P0C540, P0C542, P0CJ46, P0CJ47, P10988, P10990, P10992, P10993, P11426, P12432, P12433, P14235, P17128, P18602, P20360, P24902, P30165, P30172, P30173, P45889, P45891, P46258, P53477, P53496, P53504, P59679, P60009, P60010, P60011, P69002, P69003, P86287
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
69 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 66 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 40977 | NC_000003.12:g.169764745_169767720del | Pathogenic |
SpliceAI
115 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 3:169768346:GGTAA:G | acceptor_gain | 1.0000 |
| 3:169768348:TAA:T | acceptor_gain | 1.0000 |
| 3:169768348:TAAC:T | acceptor_loss | 1.0000 |
| 3:169768349:AA:A | acceptor_gain | 1.0000 |
| 3:169768351:C:CC | acceptor_gain | 1.0000 |
| 3:169768351:C:CG | acceptor_loss | 1.0000 |
| 3:169768353:G:C | acceptor_gain | 1.0000 |
| 3:169769316:GGTAC:G | donor_loss | 1.0000 |
| 3:169769317:GTACC:G | donor_loss | 1.0000 |
| 3:169769318:TACC:T | donor_loss | 1.0000 |
| 3:169769319:A:C | donor_loss | 1.0000 |
| 3:169768347:GTAA:G | acceptor_gain | 0.9900 |
| 3:169768353:G:GC | acceptor_gain | 0.9900 |
| 3:169768350:ACTGT:A | acceptor_gain | 0.9800 |
| 3:169768351:C:A | acceptor_gain | 0.9800 |
| 3:169768347:GTAAC:G | acceptor_gain | 0.9700 |
| 3:169768348:TAACT:T | acceptor_gain | 0.9700 |
| 3:169768349:AACT:A | acceptor_gain | 0.9700 |
| 3:169768352:T:A | acceptor_gain | 0.9700 |
| 3:169768364:A:T | acceptor_gain | 0.9700 |
| 3:169769319:A:AC | donor_gain | 0.9600 |
| 3:169769320:C:CC | donor_gain | 0.9600 |
| 3:169768363:C:CT | acceptor_gain | 0.9400 |
| 3:169769345:T:TA | donor_gain | 0.8900 |
| 3:169769321:C:G | donor_loss | 0.6700 |
| 3:169769337:T:TA | donor_gain | 0.6600 |
| 3:169768347:G:C | acceptor_gain | 0.5400 |
| 3:169769320:CCTG:C | donor_gain | 0.5300 |
| 3:169769340:T:TA | donor_gain | 0.5300 |
| 3:169768883:T:C | acceptor_gain | 0.5200 |
AlphaMissense
2469 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 3:169767915:C:A | K212N | 0.991 |
| 3:169767915:C:G | K212N | 0.991 |
| 3:169767542:A:G | W337R | 0.989 |
| 3:169767542:A:T | W337R | 0.989 |
| 3:169767625:C:G | R309P | 0.989 |
| 3:169767717:G:C | S278R | 0.988 |
| 3:169767717:G:T | S278R | 0.988 |
| 3:169767719:T:G | S278R | 0.988 |
| 3:169768298:A:G | W85R | 0.986 |
| 3:169768298:A:T | W85R | 0.986 |
| 3:169767903:A:C | C216W | 0.984 |
| 3:169767504:G:C | F349L | 0.982 |
| 3:169767504:G:T | F349L | 0.982 |
| 3:169767506:A:G | F349L | 0.982 |
| 3:169767988:A:G | L188P | 0.982 |
| 3:169768000:A:G | L184P | 0.982 |
| 3:169768105:C:T | G149D | 0.982 |
| 3:169768207:C:G | R115P | 0.982 |
| 3:169767658:C:A | G298V | 0.980 |
| 3:169767659:C:A | G298W | 0.980 |
| 3:169767532:C:T | G340D | 0.977 |
| 3:169768096:A:G | L152P | 0.977 |
| 3:169769466:C:G | A19P | 0.977 |
| 3:169767574:A:T | V326D | 0.975 |
| 3:169768068:A:C | S161R | 0.975 |
| 3:169768068:A:T | S161R | 0.975 |
| 3:169768070:T:G | S161R | 0.975 |
| 3:169769467:C:A | K18N | 0.975 |
| 3:169769467:C:G | K18N | 0.975 |
| 3:169767474:A:C | F359L | 0.974 |
dbSNP variants (sampled 300 via entrez): RS1000090994 (3:169769736 A>C,G), RS1000369014 (3:169770039 G>A), RS1000800661 (3:169770197 A>G), RS1002635219 (3:169767696 G>T), RS1003501596 (3:169769205 T>C,G), RS1005379261 (3:169769109 T>G), RS1006356195 (3:169771418 T>A,G), RS1006508464 (3:169766750 G>C), RS1008509039 (3:169769698 C>G,T), RS1009112835 (3:169768694 A>AT), RS1011104756 (3:169766996 T>C), RS1011467742 (3:169768754 T>C), RS1011553679 (3:169767240 C>T), RS1011702614 (3:169766620 C>A), RS1011854255 (3:169768562 C>G)
Disease associations
OMIM: gene MIM:608534 | disease phenotypes: MIM:127550
GenCC curated gene-disease
Mondo (1): dyskeratosis congenita, autosomal dominant 1 (MONDO:0007485)
Orphanet (1): Dyskeratosis congenita (Orphanet:1775)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
11 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002243_3 | Bladder cancer | 5.000000e-09 |
| GCST002514_2 | Melanoma | 7.000000e-07 |
| GCST004606_105 | Eosinophil count | 2.000000e-12 |
| GCST004623_30 | Neutrophil percentage of granulocytes | 6.000000e-14 |
| GCST004624_37 | Sum eosinophil basophil counts | 9.000000e-11 |
| GCST004744_12 | Lung adenocarcinoma | 5.000000e-06 |
| GCST005991_7 | Platelet count | 3.000000e-08 |
| GCST009391_1557 | Metabolite levels | 4.000000e-06 |
| GCST009391_2043 | Metabolite levels | 9.000000e-06 |
| GCST009391_48 | Metabolite levels | 2.000000e-06 |
| GCST012396_4 | Multiple myeloma | 3.000000e-08 |
EFO canonical traits (6, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004842 | eosinophil count |
| EFO:0007994 | neutrophil percentage of granulocytes |
| EFO:0005090 | basophil count |
| EFO:0004309 | platelet count |
| EFO:0009776 | ornithine measurement |
| EFO:0009777 | citrulline measurement |
MeSH disease descriptors (1)
| Descriptor | Name | Tree numbers |
|---|---|---|
| C565079 | Dyskeratosis Congenita, Autosomal Dominant (supp.) |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
24 total (human), top 24 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Acetaminophen | decreases expression, increases expression | 2 |
| Tobacco Smoke Pollution | increases expression | 2 |
| Valproic Acid | affects expression, decreases expression | 2 |
| methylmercuric chloride | decreases expression | 1 |
| arsenite | affects binding, increases reaction | 1 |
| methylparaben | decreases expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | decreases expression | 1 |
| tobacco tar | increases expression | 1 |
| S-(1,2-dichlorovinyl)cysteine | affects response to substance, increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Decitabine | decreases expression, decreases reaction | 1 |
| Sunitinib | decreases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Cannabidiol | decreases expression | 1 |
| Cisplatin | decreases expression | 1 |
| Drugs, Chinese Herbal | increases expression | 1 |
| Lipopolysaccharides | affects response to substance, increases expression | 1 |
| Naphthoquinones | increases expression | 1 |
| Smoke | decreases reaction, decreases expression | 1 |
| Cadmium Chloride | increases abundance, increases expression | 1 |
| Genistein | decreases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): dyskeratosis congenita, autosomal dominant 1, melanoma, plasma cell myeloma, urinary bladder carcinoma